دورية أكاديمية
أعرض في EDS

Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response.

التفاصيل البيبلوغرافية
العنوان: Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response.
المؤلفون: Affaticati F; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020 Antwerp, Belgium.; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium., Bartholomeus E; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium.; Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, 2610 Antwerp, Belgium.; Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute, University of Antwerp (VAXINFECTIO), 2610 Antwerp, Belgium., Mullan K; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020 Antwerp, Belgium.; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium., Damme PV; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium.; Centre for the Evaluation of Vaccination (CEV), Vaccine and Infectious Disease Institute, University of Antwerp, 2610 Antwerp, Belgium., Beutels P; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium.; Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, 2610 Antwerp, Belgium., Ogunjimi B; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium.; Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, 2610 Antwerp, Belgium.; Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute, University of Antwerp (VAXINFECTIO), 2610 Antwerp, Belgium.; Department of Paediatrics, Antwerp University Hospital, 2650 Edegem, Belgium., Laukens K; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020 Antwerp, Belgium.; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium., Meysman P; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020 Antwerp, Belgium.; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, 2020 Antwerp, Belgium.
المصدر: Vaccines [Vaccines (Basel)] 2023 Jul 13; Vol. 11 (7). Date of Electronic Publication: 2023 Jul 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG
مستخلص: The immune system acts as an intricate apparatus that is dedicated to mounting a defense and ensures host survival from microbial threats. To engage this faceted immune response and provide protection against infectious diseases, vaccinations are a critical tool to be developed. However, vaccine responses are governed by levels that, when interrogated, separately only explain a fraction of the immune reaction. To address this knowledge gap, we conducted a feasibility study to determine if multi-view modeling could aid in gaining actionable insights on response markers shared across populations, capture the immune system's diversity, and disentangle confounders. We thus sought to assess this multi-view modeling capacity on the responsiveness to the Hepatitis B virus (HBV) vaccination. Seroconversion to vaccine-induced antibodies against the HBV surface antigen (anti-HBs) in early converters ( n = 21; <2 months) and late converters ( n = 9; <6 months) and was defined based on the anti-HBs titers (>10IU/L). The multi-view data encompassed bulk RNA-seq, CD4+ T-cell parameters (including T-cell receptor data), flow cytometry data, and clinical metadata (including age and gender). The modeling included testing single-view and multi-view joint dimensionality reductions. Multi-view joint dimensionality reduction outperformed single-view methods in terms of the area under the curve and balanced accuracy, confirming the increase in predictive power to be gained. The interpretation of these findings showed that age, gender, inflammation-related gene sets, and pre-existing vaccine-specific T-cells could be associated with vaccination responsiveness. This multi-view dimensionality reduction approach complements clinical seroconversion and all single modalities. Importantly, this modeling could identify what features could predict HBV vaccine response. This methodology could be extended to other vaccination trials to identify the key features regulating responsiveness.
References: Nat Rev Cardiol. 2018 Sep;15(9):505-522. (PMID: 30065258)
Front Genet. 2021 Sep 06;12:718915. (PMID: 34552619)
Nat Methods. 2014 Mar;11(3):333-7. (PMID: 24464287)
Sci Rep. 2015 Jun 08;5:10775. (PMID: 26053859)
Indian J Med Microbiol. 2018 Jul-Sep;36(3):397-400. (PMID: 30429394)
Nat Commun. 2021 Jul 19;12(1):4385. (PMID: 34282143)
Braz J Med Biol Res. 2019;52(9):e8392. (PMID: 31411315)
Front Oncol. 2020 Jun 30;10:1065. (PMID: 32714870)
Cell Rep. 2022 Jun 28;39(13):111017. (PMID: 35767948)
Cell Mol Immunol. 2021 Jan;18(1):38-44. (PMID: 33159158)
Mamm Genome. 2016 Aug;27(7-8):358-66. (PMID: 27068925)
IEEE Trans Med Imaging. 2015 Jan;34(1):284-97. (PMID: 25203987)
Emerg Themes Epidemiol. 2008 Jan 22;5:2. (PMID: 18211676)
Hum Brain Mapp. 2020 Sep;41(13):3807-3833. (PMID: 32592530)
Sci Rep. 2021 Jan 11;11(1):464. (PMID: 33431958)
Cell. 2014 Apr 10;157(2):499-513. (PMID: 24725414)
J Korean Acad Nurs. 2013 Apr;43(2):154-64. (PMID: 23703593)
Mol Syst Biol. 2019 Mar 14;15(3):e8497. (PMID: 30872331)
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12300-6. (PMID: 25136102)
Blood Rev. 2014 Mar;28(2):41-7. (PMID: 24491804)
Front Aging. 2022 May 02;3:870489. (PMID: 35821859)
Immunity. 2010 Oct 29;33(4):516-29. (PMID: 21029962)
Sci Rep. 2017 Aug 15;7(1):8137. (PMID: 28811553)
Immunology. 2012 Jan;135(1):19-26. (PMID: 22044118)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Nat Rev Immunol. 2023 May;23(5):304-316. (PMID: 36539527)
Nat Immunol. 2022 Feb;23(2):186-193. (PMID: 35105982)
Nat Immunol. 2009 Jan;10(1):116-125. (PMID: 19029902)
Front Immunol. 2021 Dec 22;12:745541. (PMID: 35003061)
J Exp Med. 2008 Mar 17;205(3):711-23. (PMID: 18332179)
Hum Vaccin Immunother. 2020;16(2):460-464. (PMID: 31487228)
N Engl J Med. 2021 Nov 18;385(21):2010-2012. (PMID: 34648703)
Vaccine. 2015 Sep 29;33(40):5271-81. (PMID: 26232539)
Stat Appl Genet Mol Biol. 2009;8:Article28. (PMID: 19572827)
Phys Med Biol. 2022 Feb 24;67(5):. (PMID: 35108700)
Psychometrika. 2017 May 23;:. (PMID: 28536930)
Front Aging Neurosci. 2016 May 17;8:77. (PMID: 27242506)
Nat Rev Immunol. 2015 Jun;15(6):335-49. (PMID: 25976513)
Trends Immunol. 2020 Jun;41(6):457-465. (PMID: 32340868)
Nat Rev Endocrinol. 2018 Oct;14(10):576-590. (PMID: 30046148)
Proc AAAI Conf Artif Intell. 2018 Feb;2018:4406-4413. (PMID: 30416868)
Am Fam Physician. 2000 Oct 1;62(7):1565-72. (PMID: 11037074)
Ann N Y Acad Sci. 2000 Jun;908:244-54. (PMID: 10911963)
Immunol Lett. 2021 Feb;230:1-10. (PMID: 33309673)
In Vivo. 2017 Jul-Aug;31(4):723-729. (PMID: 28652447)
Vaccine. 2018 Oct 8;36(42):6282-6289. (PMID: 30205979)
Elife. 2022 Jan 25;11:. (PMID: 35074048)
BMC Bioinformatics. 2013 Mar 22;14:106. (PMID: 23522326)
Mol Syst Biol. 2018 Jun 20;14(6):e8124. (PMID: 29925568)
NPJ Parkinsons Dis. 2021 Jan 5;7(1):6. (PMID: 33402689)
معلومات مُعتمدة: Onderzoeksprogramma Artificiële Intelligentie Vlaanderen Program Flemish Government; BOF GOA: PIMS University of Antwerp
فهرسة مساهمة: Keywords: immunoinformatics; integrative algorithms; interpretable framework; predictive framework; systems vaccinology
تواريخ الأحداث: Date Created: 20230729 Latest Revision: 20230801
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10384938
DOI: 10.3390/vaccines11071236
PMID: 37515051
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-393X
DOI:10.3390/vaccines11071236